10-Q Filing

APPLIED BIOSCIENCES CORP. CIK: 1607549 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001477932-19-000451`
Period End Date	20181231
Filing Date	20190213
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	appb-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 68 Cash Flow Statement 61 Stockholders Equity 41

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance	`AccountsReceivableNet`	$887.00	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsReceivableNet`	-	USD	Point-in-time
Cash	`Cash`	$212.64K	USD	Point-in-time
Cash	`Cash`	$416.83K	USD	Point-in-time
Cash	`Cash`	$60.93K	USD	Point-in-time
Cash	`Cash`	$241.57K	USD	Point-in-time
Accounts receivable, net of allowance of nil and $887 at December 31, 2018 (unaudited) and March 31, 2018, respectively	`AccountsReceivableNetCurrent`	$12.39K	USD	Point-in-time
Accounts receivable, net of allowance of nil and $887 at December 31, 2018 (unaudited) and March 31, 2018, respectively	`AccountsReceivableNetCurrent`	$17.82K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Inventory	`InventoryNet`	$29.07K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Inventory	`InventoryNet`	$70.11K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaids and other current assets	`OtherPrepaidExpenseCurrent`	$46.76K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaids and other current assets	`OtherPrepaidExpenseCurrent`	$124.45K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$376.25K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$226.85K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.44K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.56K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Equity investments	`EquityMethodInvestments`	$468.54K	USD	Point-in-time
Equity investments	`EquityMethodInvestments`	$873.30K	USD	Point-in-time
Deposit on the acquisition of Trace Analytics, Inc.	`DepositsAssets`	$550.00K	USD	Point-in-time
Deposit on the acquisition of Trace Analytics, Inc.	`DepositsAssets`	-	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	10.50M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	11.60M	shares	Point-in-time
Other asset	`OtherAssetsNoncurrent`	$5.50K	USD	Point-in-time
Other asset	`OtherAssetsNoncurrent`	$5.50K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	10.50M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	11.60M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$1.81M	USD	Point-in-time
Common stock shares to be issued	`CommonStockSharesToBeIssued`	1.66M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$705.33K	USD	Point-in-time
Common stock shares to be issued	`CommonStockSharesToBeIssued`	263,000.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.85K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$33.13K	USD	Point-in-time
Accrued expenses	`OtherAccountsPayableAndAccruedLiabilities`	$14.04K	USD	Point-in-time
Accrued expenses	`OtherAccountsPayableAndAccruedLiabilities`	$150.25K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$183.38K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$35.88K	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at December 31, 2018 (unaudited) and March 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at December 31, 2018 (unaudited) and March 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized; 11,597,110 and 10,499,610 issued and outstanding at December 31, 2018 (unaudited) and March 31, 2018, respectively	`CommonStockValue`	$105.00	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized; 11,597,110 and 10,499,610 issued and outstanding at December 31, 2018 (unaudited) and March 31, 2018, respectively	`CommonStockValue`	$116.00	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$4.96M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$3.05M	USD	Point-in-time
Common stock to be issued, 1,656,500 and 263,000 shares at December 31, 2018 (unaudited) and March 31, 2018, respectively	`CommonStockToBeIssued238000And263000SharesAtJune302018UnauditedAndMarch312018Respectively`	$1.98M	USD	Point-in-time
Common stock to be issued, 1,656,500 and 263,000 shares at December 31, 2018 (unaudited) and March 31, 2018, respectively	`CommonStockToBeIssued238000And263000SharesAtJune302018UnauditedAndMarch312018Respectively`	$526.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.90M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.30M	USD	Point-in-time
Total Applied BioSciences Corp. Stockholders' Equity	`StockholdersEquity`	$1.64M	USD	Point-in-time
Total Applied BioSciences Corp. Stockholders' Equity	`StockholdersEquity`	$678.47K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-9.03K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-18.39K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.50M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$669.44K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$648.32K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$650.38K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.64M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.73M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.63M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$705.33K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.81M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
PRODUCT REVENUE, NET	`Revenues`	$472.51K	USD	3 Qtrs
PRODUCT REVENUE, NET	`Revenues`	$62.98K	USD	1 Quarter
PRODUCT REVENUE, NET	`Revenues`	$179.53K	USD	3 Qtrs
PRODUCT REVENUE, NET	`Revenues`	$413.11K	USD	1 Quarter
COST OF REVENUE, PRODUCT	`CostOfRevenue`	$50.37K	USD	1 Quarter
COST OF REVENUE, PRODUCT	`CostOfRevenue`	$439.74K	USD	3 Qtrs
COST OF REVENUE, PRODUCT	`CostOfRevenue`	$379.58K	USD	1 Quarter
COST OF REVENUE, PRODUCT	`CostOfRevenue`	$140.71K	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$38.83K	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$32.77K	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$12.61K	USD	1 Quarter
GROSS MARGIN	`GrossProfit`	$33.53K	USD	1 Quarter
Sales and marketing (including stock based compensation of nil, $47,111, $210,000 and $47,111, respectively)	`SellingAndMarketingExpense`	$556.17K	USD	3 Qtrs
Sales and marketing (including stock based compensation of nil, $47,111, $210,000 and $47,111, respectively)	`SellingAndMarketingExpense`	$165.31K	USD	1 Quarter
Sales and marketing (including stock based compensation of nil, $47,111, $210,000 and $47,111, respectively)	`SellingAndMarketingExpense`	$229.67K	USD	3 Qtrs
Sales and marketing (including stock based compensation of nil, $47,111, $210,000 and $47,111, respectively)	`SellingAndMarketingExpense`	$100.73K	USD	1 Quarter
General and administrative (including stock based compensation of $1,133,534, $13,889, $1,271,959 and $26,389, respectively)	`GeneralAndAdministrativeExpense`	$133.98K	USD	1 Quarter
General and administrative (including stock based compensation of $1,133,534, $13,889, $1,271,959 and $26,389, respectively)	`GeneralAndAdministrativeExpense`	$1.71M	USD	3 Qtrs
General and administrative (including stock based compensation of $1,133,534, $13,889, $1,271,959 and $26,389, respectively)	`GeneralAndAdministrativeExpense`	$358.19K	USD	3 Qtrs
General and administrative (including stock based compensation of $1,133,534, $13,889, $1,271,959 and $26,389, respectively)	`GeneralAndAdministrativeExpense`	$1.32M	USD	1 Quarter
Depreciation and Amortization	`DepreciationAndAmortization`	$877.00	USD	3 Qtrs
Depreciation and Amortization	`DepreciationAndAmortization`	$168.43K	USD	3 Qtrs
Depreciation and Amortization	`DepreciationAndAmortization`	$56.17K	USD	1 Quarter
Depreciation and Amortization	`DepreciationAndAmortization`	$292.00	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$1.42M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$2.27M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$756.29K	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$355.46K	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-717.47K	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-342.86K	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-2.24M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-1.38M	USD	1 Quarter
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	$404.76K	USD	3 Qtrs
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	-	USD	3 Qtrs
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Interest Expense	`InterestExpense`	$574.88K	USD	3 Qtrs
Interest Expense	`InterestExpense`	-	USD	1 Quarter
Interest Expense	`InterestExpense`	-	USD	3 Qtrs
Interest Expense	`InterestExpense`	$506.58K	USD	1 Quarter
Total other income, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Total other income, net	`OtherNonoperatingIncomeExpense`	$-170.12K	USD	3 Qtrs
Total other income, net	`OtherNonoperatingIncomeExpense`	-	USD	3 Qtrs
Total other income, net	`OtherNonoperatingIncomeExpense`	$-506.58K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-197.20K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-401.76K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-113.76K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-342.86K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-717.47K	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-177.41K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-2.41M	USD	3 Qtrs
Less: Net loss (income) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-9.36K	USD	3 Qtrs
Less: Net loss (income) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-7.13K	USD	1 Quarter
Less: Net loss (income) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$234.00	USD	1 Quarter
Less: Net loss (income) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-6.00K	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`ProfitLoss`	$-1.89M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`ProfitLoss`	$-711.47K	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`ProfitLoss`	$-335.73K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`ProfitLoss`	$-2.40M	USD	3 Qtrs
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	3 Qtrs
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.46M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.80M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.15M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.60M	shares	1 Quarter

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-197.20K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-401.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-113.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-342.86K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-717.47K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-177.41K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.41M	USD	3 Qtrs
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	$404.76K	USD	3 Qtrs
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	-	USD	3 Qtrs
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$437.81K	USD	3 Qtrs
Fair value of shares issued to consultants	`FairValueOfSharesIssuedToConsultants`	$649.30K	USD	3 Qtrs
Fair value of shares issued to consultants	`FairValueOfSharesIssuedToConsultants`	$112.33K	USD	3 Qtrs
Fair value of shares issued to officers and board member	`FairValueOfSharesIssuedToOfficersAndBoard`	-	USD	3 Qtrs
Fair value of shares issued to officers and board member	`FairValueOfSharesIssuedToOfficersAndBoard`	$756.25K	USD	3 Qtrs
Depreciation	`Depreciation`	$878.00	USD	3 Qtrs
Depreciation	`Depreciation`	$44.00	USD	3 Qtrs
Amortization of intangible	`AmortizationOfIntangibleAssets`	$168.38K	USD	3 Qtrs
Amortization of intangible	`AmortizationOfIntangibleAssets`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-5.44K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$992.00	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-12.30K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-41.03K	USD	3 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$12.63K	USD	3 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$77.70K	USD	3 Qtrs
Other asset	`IncreaseDecreaseInOtherOperatingAssets`	$-5.50K	USD	3 Qtrs
Other asset	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$147.49K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$20.19K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-420.70K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-788.86K	USD	3 Qtrs
Deposit on acquisition	`PaymentsForDepositsOnRealEstateAcquisitions`	$550.00K	USD	3 Qtrs
Deposit on acquisition	`PaymentsForDepositsOnRealEstateAcquisitions`	-	USD	3 Qtrs
Acquisition of equity investments	`PaymentsToAcquireBusinessesAndInterestInAffiliates`	$-68.54K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.57K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.11K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-550.00K	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.44M	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$695.00K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$75.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.52M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$695.00K	USD	3 Qtrs
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$204.19K	USD	3 Qtrs
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$180.64K	USD	3 Qtrs
CASH, BEGINNING OF PERIOD	`Cash`	$212.64K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$416.83K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$60.93K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$241.57K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$212.64K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$416.83K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$60.93K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$241.57K	USD	Point-in-time
Fair value of common stock issued upon conversion of convertible notes	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNotes`	-	USD	3 Qtrs
Fair value of common stock issued upon conversion of convertible notes	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNotes`	$1.44M	USD	3 Qtrs
Fair value of beneficial conversion feature related to issuance of convertible notes	`FairValueOfBeneficialConversionFeatureRelatedToIssuanceOfConvertibleNotes`	-	USD	3 Qtrs
Fair value of beneficial conversion feature related to issuance of convertible notes	`FairValueOfBeneficialConversionFeatureRelatedToIssuanceOfConvertibleNotes`	$437.81K	USD	3 Qtrs

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.50M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$669.44K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$648.32K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$650.38K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.64M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.73M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.63M	USD	Point-in-time
Common stock to be issued in conjunction with consulting agreement	`CommonStockToBeIssuedInConjunctionWithConsultingAgreement`	$50.00K	USD	1 Quarter
Common stock to be issued in conjunction with consulting agreement	`CommonStockToBeIssuedInConjunctionWithConsultingAgreement`	$62.33K	USD	1 Quarter
Issuance of common stock for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$75.00K	USD	1 Quarter
Issuance of common stock for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$695.00K	USD	1 Quarter
Issuance of common stock for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock previously committed but not issued, Amount	`IssuanceOfCommonStockPreviouslyCommittedButNotIssuedAmount`	-	USD	1 Quarter
Fair value of shares issued to consultant for services, Amount	`FairValueOfSharesIssuedToConsultantForServicesAmount`	$356.45K	USD	1 Quarter
Fair value of shares issued to consultant for services, Amount	`FairValueOfSharesIssuedToConsultantForServicesAmount`	$225.93K	USD	1 Quarter
Fair value of shares issued to consultant for services, Amount	`FairValueOfSharesIssuedToConsultantForServicesAmount`	$15.93K	USD	1 Quarter
Fair value of shares issued to advisory board member, Amount	`FairValueOfSharesIssuedToAdvisoryBoardMemberAmount`	$51.00K	USD	1 Quarter
Beneficial conversion feature associated with issuance of convertible notes	`DebtInstrumentConvertibleBeneficialConversionFeature`	$99.90K	USD	1 Quarter
Beneficial conversion feature associated with issuance of convertible notes	`DebtInstrumentConvertibleBeneficialConversionFeature`	$28.70K	USD	1 Quarter
Fair value of shares issued to Company Officers and board member, Shares	`FairValueOfSharesIssuedToCompanyOfficersAndBoardMemberShares`	625,000.00	shares	3 Qtrs
Fair value of shares issued to Company Officers and board member, Amount	`FairValueOfSharesIssuedToCompanyOfficersAndBoardMemberAmount`	$756.25K	USD	3 Qtrs
Fair value of shares issued to Company Officers and board member, Amount	`FairValueOfSharesIssuedToCompanyOfficersAndBoardMemberAmount`	$756.25K	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`BeneficialConversionFeatureAssociatedWithConvertibleNote`	$309.20K	USD	1 Quarter
Conversion of convertible debt	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$1.44M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-197.20K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-401.76K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-113.76K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-342.86K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-717.47K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-177.41K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-2.41M	USD	3 Qtrs
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.50M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$669.44K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$648.32K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$650.38K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.64M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.73M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.63M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.